|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6800 CAD | -1.45% |
|
-10.53% | -19.05% |
| 26/06 | Healwell AI Inc. - Shareholder/Analyst Call | |
| 17/06 | Healwell AI Inc. Completes Multi-Province Al Pilot Evaluating Its DARWEN AI Powered Smart Summary and SMART Search Solutions | CI |
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
Revenues | 4.78Cr | 5.32Cr | 73.17L | 3.9Cr | 10Cr | ||||
Total Revenues | 4.78Cr | 5.32Cr | 73.17L | 3.9Cr | 10Cr | ||||
Cost of Goods Sold, Total | 3.28Cr | 3.66Cr | 60.6L | 2.17Cr | 4.65Cr | ||||
Gross Profit | 1.5Cr | 1.66Cr | 12.57L | 1.73Cr | 5.73Cr | ||||
Selling General & Admin Expenses, Total | 3.3Cr | 2.94Cr | 1.4Cr | 4.51Cr | 3.79Cr | ||||
Provision for Bad Debts | - | - | - | - | - | ||||
Stock-Based Compensation (IS) | - | - | - | - | 1.3Cr | ||||
R&D Expenses | 2L | 81.44L | 48.11L | 57.95L | 1.64Cr | ||||
Depreciation & Amortization - (IS) | - | - | - | - | 25.95L | ||||
Amortization of Goodwill and Intangible Assets - (IS) | - | - | - | - | 1.43Cr | ||||
Other Operating Expenses, Total | 3.32Cr | 3.76Cr | 1.88Cr | 5.09Cr | 8.42Cr | ||||
Operating Income | -1.81Cr | -2.1Cr | -1.76Cr | -3.36Cr | -2.69Cr | ||||
Interest Expense, Total | -5L | -5L | -15.79L | -26.1L | -1.02Cr | ||||
Interest And Investment Income | 1L | 62T | 2L | 6L | 6L | ||||
Net Interest Expenses | -4L | -4L | -13.35L | -19.72L | -95.91L | ||||
Income (Loss) On Equity Invest. | - | -2L | - | - | - | ||||
Currency Exchange Gains (Loss) | - | - | - | - | -21.51L | ||||
Other Non Operating Income (Expenses) | -1L | -3L | -4L | -10L | 45.18L | ||||
EBT, Excl. Unusual Items | -1.86Cr | -2.19Cr | -1.93Cr | -3.65Cr | -3.41Cr | ||||
Merger & Related Restructuring Charges | - | - | - | - | -26.33L | ||||
Impairment of Goodwill | - | - | -53.54L | -45.13L | - | ||||
Gain (Loss) On Sale Of Investments | - | -4L | -23.14L | 3L | 12.03L | ||||
Gain (Loss) On Sale Of Assets | - | - | - | - | -14.23L | ||||
Asset Writedown | - | - | -55.42L | -11L | - | ||||
Insurance Settlements | 7L | 9L | 8L | - | - | ||||
Other Unusual Items | 16.35L | 16.43L | -9L | 1.35Cr | -28.1L | ||||
EBT, Incl. Unusual Items | -1.63Cr | -1.98Cr | -3.27Cr | -2.83Cr | -3.98Cr | ||||
Income Tax Expense | -7L | 12.17L | -5L | -9L | -7L | ||||
Earnings From Continuing Operations | -1.55Cr | -2.1Cr | -3.21Cr | -2.74Cr | -3.91Cr | ||||
Earnings Of Discontinued Operations | - | - | 6L | -54T | -85.44L | ||||
Net Income to Company | -1.55Cr | -2.1Cr | -3.15Cr | -2.75Cr | -4.77Cr | ||||
Minority Interest | -1L | -1L | -52T | 11.87L | 6L | ||||
Net Income - (IS) | -1.57Cr | -2.11Cr | -3.16Cr | -2.63Cr | -4.71Cr | ||||
Net Income to Common Incl Extra Items | -1.57Cr | -2.11Cr | -3.16Cr | -2.63Cr | -4.71Cr | ||||
Net Income to Common Excl. Extra Items | -1.57Cr | -2.11Cr | -3.22Cr | -2.62Cr | -3.86Cr | ||||
Per Share Items | |||||||||
Net EPS - Basic | -0.33 | -0.42 | -0.55 | -0.19 | -0.19 | ||||
Basic EPS - Continuing Operations | -0.33 | -0.42 | -0.56 | -0.19 | -0.15 | ||||
Basic Weighted Average Shares Outstanding | 4.8Cr | 5.01Cr | 5.7Cr | 14Cr | 25Cr | ||||
Net EPS - Diluted | -0.33 | -0.42 | -0.55 | -0.19 | -0.19 | ||||
Diluted EPS - Continuing Operations | -0.33 | -0.42 | -0.56 | -0.19 | -0.15 | ||||
Diluted Weighted Average Shares Outstanding | 4.8Cr | 5.01Cr | 5.7Cr | 14Cr | 25Cr | ||||
Normalized Basic EPS | -0.24 | -0.28 | -0.21 | -0.16 | -0.08 | ||||
Normalized Diluted EPS | -0.24 | -0.28 | -0.21 | -0.16 | -0.08 | ||||
Payout Ratio | - | -0.55 | - | - | - | ||||
Supplemental Items | |||||||||
EBITDA | -1.71Cr | -1.95Cr | -1.61Cr | -3.14Cr | -2.06Cr | ||||
EBITA | -1.75Cr | -1.99Cr | -1.66Cr | -3.18Cr | -2.12Cr | ||||
EBIT | -1.81Cr | -2.1Cr | -1.76Cr | -3.36Cr | -2.69Cr | ||||
EBITDAR | -1.59Cr | -1.78Cr | -1.53Cr | - | - | ||||
Total Revenues (As Reported) | - | - | - | - | 10Cr | ||||
Effective Tax Rate - (Ratio) | 4.59 | -6.16 | 1.66 | 3.03 | 1.66 | ||||
Total Current Taxes | 47T | 3L | 19T | 4L | 9L | ||||
Total Deferred Taxes | -8L | 10L | -6L | -12.13L | -15.91L | ||||
Normalized Net Income | -1.18Cr | -1.38Cr | -1.21Cr | -2.16Cr | -2.08Cr | ||||
Interest on Long-Term Debt | 5L | 5L | 5L | 7L | 48.64L | ||||
Supplemental Operating Expense Items | |||||||||
Selling and Marketing Expenses | 11.15L | 16.56L | 12.8L | 23.81L | 88.76L | ||||
General and Administrative Expenses | 1.83Cr | 1.23Cr | 90.57L | 4.27Cr | 2.9Cr | ||||
Research And Development Expense From Footnotes | 2L | 81.44L | 48.11L | 57.95L | 1.64Cr | ||||
Net Rental Expense, Total | 11.07L | 16.38L | 8L | - | - | ||||
Imputed Operating Lease Interest Expense | 3L | 4L | 5L | - | - | ||||
Imputed Operating Lease Depreciation | 8L | 12.35L | 3L | - | - | ||||
Stock-Based Comp., G&A Exp. (Total) | 61.11L | 30.13L | 27.52L | - | - | ||||
Stock-Based Comp., Other (Total) | - | 18.21L | 5L | 71.41L | 1.3Cr | ||||
Total Stock-Based Compensation | 61.11L | 48.34L | 32.61L | 71.41L | 1.3Cr |
- Stock Market
- Stocks
- AIDX Stock
- Financials Healwell AI Inc.
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















